Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.
about
Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinAge and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central ChinaSASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infectionGenetic diversity of hepatitis C virus in Ethiopia.Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.New insight into HCV E1/E2 region of genotype 4a.Genotypes and subtypes of hepatitis C virus in Burundi: a particularity in sub-Saharan Africa.Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from BelgiumSASLT guidelines: Update in treatment of Hepatitis C virus infection.The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi ArabiaMolecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 InfectionEffects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
P2860
Q26784321-8C29D386-AF97-411E-96F8-776CD50DCCE7Q27468718-BFEEAAE0-8CA1-47DB-9D36-8CB34E7051CFQ28082474-8F136512-8379-4F82-99E7-CE051DF1AEE6Q33752089-C37AFBFD-0B75-473C-91F6-018FF6FE4181Q34270336-80246843-40F9-42C9-AADC-0BFE2DBEBBF9Q35005196-DA1CCF1A-E987-47D5-9152-166DE2EABE06Q35090280-1FBAF174-6252-45EE-9BF8-614769B42E38Q35563500-F97EB91A-8D1A-4588-BD8A-3BFFE262E819Q36140466-019F394A-EA37-4943-9BFE-BE158F770373Q36261373-51F853D6-51DD-4616-B397-17F8033ACDA7Q37216507-B247EC7B-697F-4C81-B4ED-0647B362427AQ37712968-AC7DC13B-EA67-40EF-8AD4-9A18455A7569Q40061350-B7D8436B-FF5E-4E12-B2A1-BAA3F0C5DB4DQ40741996-187D44E2-A2C3-4174-9495-16EDEC390ABAQ42212782-07159225-6F6C-407B-BAD5-466BF410BB20Q59125732-2634E6E5-3F31-4A6D-B826-23070E20C481
P2860
Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@ast
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@en
type
label
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@ast
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@en
prefLabel
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@ast
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@en
P2093
P2860
P356
P1476
Hepatitis C genotype 4: genoty ...... e of subtypes in Saudi Arabia.
@en
P2093
Ahmad Salem Helmy
Ahmed Al Qahtani
Faisal M Sanai
Hamad I Al Ashgar
Mohammed Al-Ahdal
Mohammed Q Khan
Sahar Al Thawadi
P2860
P356
10.4103/1319-3767.105920
P577
2013-01-01T00:00:00Z